July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Deletion of Tribbles Pseudokinase-3 Ameliorates Retinal Function in CEP290RD16 Mice
Author Affiliations & Notes
  • Asif Elahi
    Optometry and Vision Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Priyamvada M Pitale
    Optometry and Vision Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Takashi Satoh
    Osaka University, Japan
  • Shizuo Akira
    Osaka University, Japan
  • Marina S Gorbatyuk
    Optometry and Vision Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Footnotes
    Commercial Relationships   Asif Elahi, None; Priyamvada Pitale, None; Takashi Satoh, None; Shizuo Akira, None; Marina Gorbatyuk, None
  • Footnotes
    Support  R01 EY027763
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2366. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Asif Elahi, Priyamvada M Pitale, Takashi Satoh, Shizuo Akira, Marina S Gorbatyuk; Deletion of Tribbles Pseudokinase-3 Ameliorates Retinal Function in CEP290RD16 Mice. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2366.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : CEP290RD16 mice expressing truncated CEP290 (Centrosomal protein 290) mimic Leber congenital amaurosis (LCA) in humans, a severe inherited retinal dystrophy with early onset of photoreceptor degeneration. Cellular mechanisms involved in retinal pathogenesis of CEP290RD16 mouse retinas include activation of Integrated Stress Response, endoplasmic reticulum (ER) stress markers, tribbles pseudokinase-3 (TRB3) gene by p-eIF2α→ ATF4→ CHOP signaling, and inhibition of phosphorylated (p) serine/threonine-protein kinase AKT and mechanistic target of rapamycin (mTOR). Moreover, reduction in p-AKT→p-mTOR arm in CEP290RD16 retinas is known to be associated with reduced rate of protein synthesis. Therefore, the purpose of this study was to evaluate the impact of TRB3 deletion on progression of retinal degeneration in CEP290RD16 mice.

Methods : CEP290RD16 were bred with TRB3-/- mice. Retinal functions of CEP290RD16 TRB3-/-; CEP290RD16; TRB3 -/- and C57BL6 mice were evaluated by registration of a- and b-wave amplitudes of the scotopic ERGs at postnatal (P) day 18. Number of rows of photoreceptor nuclei were counted in H&E stained mouse retinas at P18. At P15, we isolated retinal protein extracts to detect phosphorylation of AKT→mTOR and eIF2α signaling in all four groups of animals. Statistical analysis was done using one-way ANOVA software in all groups.

Results : Analysis of the scotopic ERGs revealed dramatic increase in both a- and b-wave amplitudes in CEP290RD16 TRB3-/- by 133.56% and 268.64%, respectively as compared to CEP290RD16 mice. These data correlated with the increase in the number of photoreceptor nuclei in CEP290RD16 TRB3-/- (6.45 rows vs 4.29 rows in CEP290RD16 mice) at P18. In addition, we found that levels of p-mTOR was elevated in CEP290RD16 TRB3 ablated retinas by 66.45% and the p-eIF2α level was decreased by 35.79% as compared to CEP290RD16. These data indicate a potential increase in the rate of protein synthesis and decrease in ER stress, respectively.

Conclusions : Our results depict that deletion of TRB3 gene in CEP290RD16 mouse model of retina degeneration improves the overall retinal structure and function resulting in increase in the ERG amplitudes, photoreceptor survival, elevated p-mTOR and the eIF2α deactivation. This strategy may be useful as a therapy to treat retina degenerative diseases in future, however, all other safety parameters need to be accessed first for future implications.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×